Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis

Erratum to: Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis

Journal of Gastroenterology ◽

10.1007/s00535-016-1192-2 ◽

2016 ◽

Vol 51 (7) ◽

pp. 750-750

Author(s):

Hidenori Toyoda ◽

Takashi Kumada ◽

Toshifumi Tada ◽

Koichi Takaguchi ◽

Toru Ishikawa ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Therapy ◽

Genotype 1 ◽

Virus Genotype ◽

Safety And Efficacy ◽

Direct Acting Antiviral ◽

Direct-acting antiviral therapy for chronic hepatitis C virus genotype 4 infection: Exploring new regimens

Health Science Reports ◽

10.1002/hsr2.106 ◽

2019 ◽

Vol 2 (3) ◽

pp. e106 ◽

Cited By ~ 1

Author(s):

Hidenori Toyoda

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Therapy ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype 4 ◽

Direct Acting Antiviral ◽

Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6

Journal of Viral Hepatitis ◽

10.1111/jvh.13132 ◽

2019 ◽

Author(s):

Eric Lawitz ◽

Edward Gane ◽

Jordan J. Feld ◽

Maria Buti ◽

Graham R. Foster ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Agent ◽

Efficacy And Safety ◽

Genotype 1 ◽

Virus Genotype ◽

Direct Acting Antiviral ◽

MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure

Journal of Hepatology ◽

10.1016/s0168-8278(17)30432-4 ◽

2017 ◽

Vol 66 (1) ◽

pp. S83-S84 ◽

Cited By ~ 14

Author(s):

F. Poordad ◽

S. Pol ◽

A. Asatryan ◽

M. Buti ◽

D. Shaw ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Treatment Failure ◽

Antiviral Treatment ◽

Genotype 1 ◽

Virus Genotype ◽

Direct Acting Antiviral ◽

Effect of direct acting antiviral therapy of Chronic Hepatitis C virus on insulin resistance and Type2 DM in Egyptian patients (prospective study)

Diabetes & Metabolic Syndrome Clinical Research & Reviews ◽

10.1016/j.dsx.2019.07.032 ◽

2019 ◽

Vol 13 (4) ◽

pp. 2641-2646

Author(s):

Maher BM. Boraie ◽

Yasser A. Elnaggar ◽

Mohammed Othman Ahmed ◽

Ahmed M. Mahmoud

Keyword(s):

Insulin Resistance ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Prospective Study ◽

Antiviral Therapy ◽

Direct Acting Antiviral ◽

Egyptian Patients ◽

Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong

Digestive Diseases and Sciences ◽

10.1007/s10620-020-06281-8 ◽

2020 ◽

Cited By ~ 1

Author(s):

Man-Fung Yuen ◽

Sze-Hang Liu ◽

Wai-Kay Seto ◽

Lung-Yi Mak ◽

Shelby L. Corman ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hong Kong ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Utility ◽

Genotype 1 ◽

Direct Acting Antiviral ◽

Cost-effectiveness of direct-acting antiviral regimen ombitasvir/paritaprevir/ritonavir in treatment-naïve and treatment-experienced patients infected with chronic hepatitis C virus genotype 1b in Japan

Journal of Medical Economics ◽

10.1080/13696998.2016.1206908 ◽

2016 ◽

Vol 19 (12) ◽

pp. 1144-1156 ◽

Cited By ~ 10

Author(s):

Suchin Virabhak ◽

Kikuo Yasui ◽

Kiyotaka Yamazaki ◽

Scott Johnson ◽

Dominic Mitchell ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Direct Acting Antiviral ◽

Treatment Naïve ◽

Liver stiffness predicts relapse after Direct acting antiviral therapy against chronic Hepatitis C Virus infection

Journal of Hepatology and Gastrointestinal disorders ◽

10.4172/2475-3181-c1-002 ◽

2018 ◽

Vol 04 ◽

Author(s):

Ali Abdelrahman Sayed

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Antiviral Therapy ◽

Liver Stiffness ◽

Hepatitis C Virus Infection ◽

Direct Acting Antiviral ◽

Effectiveness of sofosbuvir based direct-acting antiviral regimens for chronic hepatitis C virus genotype 6 patients: Real-world experience in Vietnam

PLoS ONE ◽

10.1371/journal.pone.0233446 ◽

2020 ◽

Vol 15 (5) ◽

pp. e0233446

Author(s):

Dung Thanh Nguyen ◽

Thanh Thi Thanh Tran ◽

Ngoc My Nghiem ◽

Phuong Thanh Le ◽

Quang Minh Vo ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real World ◽

Virus Genotype ◽

Direct Acting Antiviral ◽

Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct‐acting antiviral therapy

Journal of Medical Virology ◽

10.1002/jmv.25448 ◽

2019 ◽

Vol 91 (7) ◽

pp. 1307-1312 ◽

Cited By ~ 2

Author(s):

Fred Poordad ◽

Michael Bennett ◽

Thomas E. Sepe ◽

Eric Cohen ◽

Robert W. Reindollar ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Therapy ◽

Genotype 1 ◽

Virus Genotype ◽

Direct Acting Antiviral ◽